Skip to main content
OpenTrials

Clinical trial condition

Gallbladder Neoplasms

Explore clinical trials studying Gallbladder Neoplasms. Study availability and eligibility vary by location and protocol.

214 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Gallbladder Neoplasms trial results

Active, not recruiting

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

NCT05564403

Conditions
Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 207 locations
View Trial Details
Active, not recruiting

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

NCT06109779

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
View all 177 locations
View Trial Details
Active, not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, not recruiting

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

NCT03257761

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +45 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer

NCT06178445

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
Locations
  • Universitätsklinikum Augsburg Augsburg, Germany
  • Charité Universitätsmedizin Berlin, Germany
  • Krankenhaus Nordwest (KHNW) Frankfurt, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
View Trial Details
Active, not recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Active, not recruiting

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

NCT04941287

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +20 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, not recruiting

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer

NCT02170090

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
Locations
  • Bankstown Hospital Bankstown, New South Wales, Australia
  • Nepean Hospital Cancer Care Kingswood, New South Wales, Australia
  • St. George Hospital Kogarah, New South Wales, Australia
  • Prince of Wales Hospital Randwick, New South Wales, Australia
View all 67 locations
View Trial Details

Related conditions